Elucidating drug resistance in human fungal pathogens
Fungal pathogens cause life-threatening infections in immunocompetent and
immunocompromised individuals. Millions of people die each year due to fungal infections …
immunocompromised individuals. Millions of people die each year due to fungal infections …
[图书][B] Recent trends in antifungal agents and antifungal therapy
A Basak, R Chakraborty, SM Mandal - 2016 - Springer
In the history of discoveries of fungal pathogens, the nineteenth century has witnessed two
important events. The causal organism of a silkworm disease, muscardine, a fungus named …
important events. The causal organism of a silkworm disease, muscardine, a fungus named …
[图书][B] Combating fungal infections: problems and remedy
Fungi are eukaryotic microorganisms that are closely related to humans at cellular level.
Human fungal pathogens belong to various classes of fungi, mainly zygo-cetes …
Human fungal pathogens belong to various classes of fungi, mainly zygo-cetes …
[HTML][HTML] Current and future antifungal therapy: new targets for antifungal therapy
VT Andriole - International journal of antimicrobial agents, 2000 - Elsevier
Invasive fungal infections will continue to cause major complications in
immunocompromized patients. At the moment, the expansion of antifungal drug research …
immunocompromized patients. At the moment, the expansion of antifungal drug research …
Emerging new targets for the treatment of resistant fungal infections
N Liu, J Tu, G Dong, Y Wang… - Journal of medicinal …, 2018 - ACS Publications
With the increasing morbidity and mortality of invasive fungal infections and the emergence
of severe antifungal drug resistance, new drug targets and novel antifungal agents are …
of severe antifungal drug resistance, new drug targets and novel antifungal agents are …
Novel avenues for identification of new antifungal drugs and current challenges
J Jampilek - Expert Opinion on Drug Discovery, 2022 - Taylor & Francis
Introduction Some of the fungi have become pathogenic to humans, and these opportunistic
pathogens are able to cause severe systemic mycoses. Areas covered The number of …
pathogens are able to cause severe systemic mycoses. Areas covered The number of …
Antimycotic drugs and their mechanisms of resistance to Candida species
S Dahiya, N Sharma, A Punia, P Choudhary… - Current Drug …, 2022 - ingentaconnect.com
Fungal infections have shown an upsurge in recent decades, which is mainly because of the
increasing number of immunocompromised patients and the occurrence of invasive …
increasing number of immunocompromised patients and the occurrence of invasive …
Therapy for fungal diseases: opportunities and priorities
DW Denning, WW Hope - Trends in microbiology, 2010 - cell.com
This article provides a perspective on the current status of drug therapy for invasive fungal
diseases, together with priorities for the future development of novel compounds. Key …
diseases, together with priorities for the future development of novel compounds. Key …
New treatment options for critically important WHO fungal priority pathogens
Background Yet often overlooked in public health discourse, fungal infections pose a
crucialglobal disease burden associated with annual mortality rates approximately equal to …
crucialglobal disease burden associated with annual mortality rates approximately equal to …
Drug repurposing strategies in the development of potential antifungal agents
Q Zhang, F Liu, M Zeng, Y Mao, Z Song - Applied Microbiology and …, 2021 - Springer
The morbidity and mortality caused by invasive fungal infections are increasing across the
globe due to developments in transplant surgery, the use of immunosuppressive agents …
globe due to developments in transplant surgery, the use of immunosuppressive agents …